advertisements
26.02.2024
Expert*in Governance für Recruitingprozesse inkl. Vendormanagement (m/w/d)
Germany, Frankfurt Taunusanlage 12
... regionalen Projekten mit. Ihre Erfahrungen und Fähigkeiten Sie verfügen über ein abgeschlossenes Hochschulstudium oder vergleichbare Qualifikationen sowie über fundierte einschlägige Berufserfahrung im Personalbereich, idealerweise im Recruiting oder in vergleichbaren Bereichen/Tätigkeiten. Sie ...
More »
0010 Deutsche Bank Aktiengesellschaft
12.08.2024
Defense System Engineer – TelecomSecurity
Italy, Firenze
... Engineer in both Customer and RD contexts, particularly for Defense business. Hereafter the main related responsibilities are listed: To scout continuously the Defense Market and the Thales Products Portfolio in order to find innovative solutions, following especially the digital transformation ...
More »
Thales Italia S.P.A.
23.02.2024
Mission Assurance Engineer
United States of America, UTCLB14
... Engineer. The Mission Assurance team monitors mission assurance program specifications and processes to ensure the mission success of the program and works with the various teams to promote continuous MRB reduction and process improvements are implemented. In addition, we assess program ...
More »
0899 AS - Aerospace Structures
13.10.2023
Regulatory Liaison Specialist - Vice President
United States of America, New York, 1 Columbus Circle
... regional diversification and substantial revenue streams from all the major regions of the world. We serve our clients’ real economic needs in commercial banking, investment banking, private banking, and asset management; We are investing heavily in digital technologies, prioritizing long term ...
More »
0839 Deutsche Bank Aktiengesellschaft, Filiale New York
09.07.2023
chef de projet et coordonnateur du contenu graphique aux Affaires réglementaires / Regulatory Affairs Project Leader, Artwork Coordinator
Canada, Montreal Queen Street
... avons obtenu 13 approbations importantes. Nous avons plus que doublé le nombre de nouveaux vaccins et de médicaments en cours d’études cliniques de phase III, qui s’élèvent maintenant à 23 au total. Nos produits en développement, soit 21 vaccins et 43 médicaments, pourraient s’avérer être les ...
More »
837 GlaxoSmithKline Inc.